Simone Ferrero, MD1,2, Daniele Grimaldi, MD2*, Elena Arrigoni3*, Gian Maria Zaccaria, PhD2*, Beatrice Alessandria2*, Elisa Genuardi2*, Gabriele De Luca2*, Marco Ghislieri4*, Alice Di Rocco5*, Alessandro Re, MD6*, Vittorio Stefoni, MD, PhD7*, Federica Cavallo1,2*, Carola Boccomini, MD8*, Monica Balzarotti9*, Vittorio Ruggero Zilioli, MD10*, Gomes da Silva Maria, MD, PhD11*, Luca Arcaini12*, Anna Lia Molinari, MD13*, Filippo Ballerini, MD14*, Andres JM Ferreri, MD15, Benedetta Puccini16*, Giuseppe A. Palumbo, MD, PhD17*, Sara Galimberti, MD, PhD18*, Sergio Cortelazzo, MD19*, Antonello Di Paolo3* and Marco Ladetto, MD20
1Hematology, University of Torino and Hospital "Città della Salute e della Scienza di Torino", Torino, Italy
2Department of Molecular Biotechnologies and Health Sciences, Hematology Division, University of Torino, Torino, Italy
3Pharmacology Unit, University of Pisa, Pisa, Italy
4Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy
5Department of Translational and Precision Medicine, Policlinico Umberto I, Roma, Italy
6ASST Spedali Civili, Brescia, ID, Italy
7Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
8Hematology Division 2, AOU "Città della Salute e della Scienza di Torino", Turin, Italy
9Department of Haematology, Istituto Clinico Humanitas, Rozzano, Italy
10Ospedale Metropolitano Niguarda, Milano, IT-MI, Italy
11Instituto Português de Oncologia - Centro de Lisboa, Departamento de Hematologia, Lisboa, Portugal
12Department of Onco-Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
13Hematology Unit, Infermi Hospital, Rimini (FC), Italy
14Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
15Onco-Hematology Department, Fondazione Centro San Raffaele, Milan, Italy
16Hematology Department, University of Florence and AOU Careggi, Firenze, Italy
17Department of Medical, Surgical and Advanced Technology "G.F. Ingrassia", University of Catania, Catania, Italy
18Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
19Clinica Humanitas/Gavazzeni, Bergamo, Italy
20Division of Hematology, A.O. SS Antonio e Biagio and Cesare Arrigo, Alessandria, Italy
Disclosures: Ferrero: Servier: Speakers Bureau; Gilead: Research Funding, Speakers Bureau; EUSA Pharma: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Janssen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau. Boccomini: SC Ematologia, ASOU Città della Salute e della Scienza di Torino, Turin, Italy: Current Employment. Maria: Roche: Consultancy, Other: travel, accomodations, expenses; Abbvie: Consultancy, Other: travel, accomodations, expenses; BMS: Consultancy; MSD: Consultancy; Janssen: Consultancy, Other: travel, accomodations, expenses; Gilead: Consultancy, Other: travel, accomodations, expenses, Research Funding. Ferreri: Gilead: Membership on an entity's Board of Directors or advisory committees, Research Funding; Morphosys: Research Funding; Hutchinson: Research Funding; BMS: Research Funding. Palumbo: Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Amgen: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau. Galimberti: Novartis: Speakers Bureau; Incyte: Honoraria.
OffLabel Disclosure: Lenalidomide maintenance in mantle cell lymphoma